Nice, France

Vincent Malnuit


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vincent Malnuit: Innovator in Cancer Treatment

Introduction

Vincent Malnuit is a notable inventor based in Nice, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on the development of Acadesine derivatives, which have therapeutic applications in treating various forms of cancer.

Latest Patents

Vincent Malnuit holds a patent for "Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same." This patent describes Acadesine derivatives as a drug, particularly for the treatment of chronic myeloid leukemia. The patent outlines the use of these derivatives in combination with at least one other active ingredient for cancer treatment. Additionally, it details a pharmaceutical composition containing the derivatives and a pharmaceutically acceptable carrier. The patent also includes methods for inhibiting in vitro cell proliferation by placing cells in contact with the derivatives.

Career Highlights

Throughout his career, Vincent Malnuit has worked with esteemed institutions such as Université Nice Sophia Antipolis and the Centre National de la Recherche Scientifique. His research has contributed to advancements in cancer therapies, showcasing his dedication to improving patient outcomes.

Collaborations

Vincent has collaborated with notable colleagues, including Rachid Benhida and Patrick Auberger. Their combined expertise has furthered the development of innovative solutions in the field of cancer treatment.

Conclusion

Vincent Malnuit's contributions to cancer research through his patented Acadesine derivatives highlight his role as an influential inventor. His work continues to pave the way for new therapeutic approaches in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…